July 2025- Allele Biotechnology Awarded U.S. Patent for Stem Cell-Based β-Cell Differentiation Method
San Diego, CA — Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based biotechnology company specializing in induced pluripotent stem cell (iPSC) technologies and regenerative medicine, today announced the issuance of U.S. Patent No. 12,338,462 by the United States Patent and Trademark Office (USPTO). The patent, titled “Induction of Pancreatic β-Cells by Stem Cell Differentiation with…